Delivery Order SPE2DB22D1017-SPE2DB25FG8VX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,533.99 to AmerisourceBergen Drug Corp for Qualtipta 60 mg tablets (30-count) on July 28, 2025, with performance through July 29, 2025. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $4,027.02 delivery order to AmerisourceBergen Drug Corp for Quilpta 60 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $4,276.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Qualiptia 60 mg on July 21, 2025, with completion targeted for July 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $4,337.55 to AmerisourceBergen Drug Corp for the supply of Qualiptа 30 mg tablets (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Qualipro 60 mg tablets (30-count units) with a ceiling value of $8,351.83. This firm fixed-price delivery order, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, was competitively awarded without set-aside designation. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $1,157.61 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qualiptia 60 mg tablets in a quantity of 30 units. This contract, which is a non-set-aside award issued under firm fixed pricing, is scheduled for completion by July 31, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award to AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,547.07 delivery order to AmerisourceBergen Drug Corp for Qulipta 60 mg tablets (30-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will be...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,153.06 firm fixed-price delivery order is for the QULIPTA 60 MG TABLET 30S medical product, with a completion date of July 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $4,300.89 for Qualipita 60 mg tablets (30-count units) by the Defense Logistics Agency's Medical Supply Chain. The contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a competitively awarded, non-set-aside order under a firm fixed-price arrangement. The place of performance is located in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $37,266.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8VXDelivery Order
The Defense Logistics Agency awarded a $6,894.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Qualtipta 60 mg tablets, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems across multiple therapeutic domains. AmerisourceBergen's DLA contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contract portfolio demonstrates consistent performance in fulfilling military medical supply requirements through competitive delivery orders with firm fixed pricing across varying transaction values, positioning it as a key supplier within the federal pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 8/4/25 |